The 10th Annual Global Pharma Regulatory Affairs Summit 2021 will be held from May 25 to 28. A premier pharma regulatory event for the Indian generics and biosimilars industries, featuring timely programmed and relevant to the technical and regulatory agenda. This summit will bring together pharma regulatory operations and submission professionals to learn best practices in the compilation, formatting and submission of a variety of approval applications.
Houri Simonian will be presenting the workshop on May 28 in the morning titled Nitrosamines Testing: The Regulatory Aspects. The workshop will explore relevant aspects of root cause analysis and risk assessment with respect to potential nitrosamine contamination in drug substances and drug products.
Houri Simonian, PhD, has held the position of Director of Chemistry for SGS Mississauga for the past 5 years. She has more than 20 years of experience in the pharmaceutical industry, including R&D and drug development.
SGS offers high quality analytical testing and end-to-end clinical trial solutions for pharmaceutical and biopharmaceutical products through all phases of drug development, from discovery through early development and commercialization.
We offer expert guidance from our experienced consulting and project management teams, so you can get your products to market quickly, safely and cost-effectively.
For further information, please contact:
Head of Marketing
t: +41 22 739 91 11